Clinical trial
The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
NCT07612878 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- Lead sponsor
- Sanofi
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 6, 2026
- Completion date
- November 30, 2029
- Enrollment
- 350 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
copd (chronic obstructive pulmonary disease)